Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2013
03/19/2013CA2514092C Novel cocrystallization of hydrochloric acid salt of an active agent
03/19/2013CA2513251C Cancer therapy sensitizer
03/19/2013CA2499278C Method of preparing dry powder inhalation compositions
03/19/2013CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions
03/19/2013CA2435363C New inhibitors against galectins
03/19/2013CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same
03/19/2013CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals
03/19/2013CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/19/2013CA2195334C Compositions and methods for enhanced tumor cell immunity in vivo
03/15/2013DE202009018772U1 Zusammensetzung enthaltend Vitamin K und ihre Verwendung A composition comprising vitamin K, and their use
03/14/2013WO2013036961A1 A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof
03/14/2013WO2013036912A2 Amido compounds as rorϒtmodulators and uses thereof
03/14/2013WO2013036879A1 Compositions and methods for treating prostate cancer
03/14/2013WO2013036866A1 Itraconazole analogs and use thereof
03/14/2013WO2013036844A2 Methods for treatment of and prophylaxis against hemorrhoids
03/14/2013WO2013036835A1 Neuroactive steroids, compositions, and uses thereof
03/14/2013WO2013036799A2 Methods and compositions involving nkg2d inhibitors and cancer
03/14/2013WO2013036783A2 Methods for treating intrapulmonary infections
03/14/2013WO2013036775A1 Silicone coated implants
03/14/2013WO2013036753A1 Chiral compounds of varying conformational rigidity and methods of synthesis
03/14/2013WO2013036720A1 Methods for treatment of cancer by targeting sirt5
03/14/2013WO2013036712A1 Compositions including beta-glucans and methods of use
03/14/2013WO2013036679A1 Compounds useful for treating neurodegenerative disorders
03/14/2013WO2013036676A1 Hiv inhibitors
03/14/2013WO2013036674A1 Compounds useful for treating neurodegenerative disorders
03/14/2013WO2013036669A1 Compounds useful for treating neurodegenerative disorders
03/14/2013WO2013036665A1 Compounds for use in treating neurodegenerative disorders, synthesis thereof, and intermediates thereto
03/14/2013WO2013036563A1 Pharmaceutical compositions comprising an aromatase inhibitor
03/14/2013WO2013036562A1 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases
03/14/2013WO2013036530A1 3-(4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators
03/14/2013WO2013036464A1 Gamma secretase inhibitors
03/14/2013WO2013036434A1 Tetrahydronaphthalene derivatives as t-type calcium channel blocker
03/14/2013WO2013036403A1 TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES
03/14/2013WO2013036301A1 Induced tolerogenic dendritic cells for inducing regulatory b cells
03/14/2013WO2013036300A1 Compositions and methods related to induced tolerogenic dedritic cells externally loaded with mhc class i-restricted epitopes
03/14/2013WO2013036286A2 Retinal cyclodextrin acetals and hemiacetals for clarifying skin complexion
03/14/2013WO2013036232A2 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
03/14/2013WO2013036224A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy
03/14/2013WO2013036213A1 Dpp-iv inhibitor formulations
03/14/2013WO2013036207A1 Derivatives of xanthone compounds
03/14/2013WO2013036196A1 Novel thiophene compounds and method for in vivo imaging
03/14/2013WO2013036153A1 An anthracycline for the treatment of sepsis
03/14/2013WO2013036122A1 Use of infant formula with large lipid globules
03/14/2013WO2013036119A1 Use of infant formula with cholesterol
03/14/2013WO2013036103A1 Use of infant formula with large lipid globules
03/14/2013WO2013036102A1 Use of infant formula with cholesterol
03/14/2013WO2013036081A2 Composition for reducing skin wrinkles including pde5 inhibitor
03/14/2013WO2013036072A1 Injectable therapeutic agent for arthritis
03/14/2013WO2013035997A2 Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt
03/14/2013WO2013035943A1 Betulinic acid having anti-aging activity and derivatives thereof, and composition containing same
03/14/2013WO2013035895A1 Novel apoptosis regulator
03/14/2013WO2013035892A1 Piperazine- substituted benzothiophene derivatives as antipsychotic agents
03/14/2013WO2013035850A1 Transdermal preparation
03/14/2013WO2013035837A1 Method for suppressing decrease in viscosity of aqueous liquid agent
03/14/2013WO2013035833A1 Morphinan derivative
03/14/2013WO2013035827A1 Novel olefin derivative
03/14/2013WO2013035826A1 Fused heterocyclic compound
03/14/2013WO2013035824A1 Cancer stem cell isolation
03/14/2013WO2013035797A1 Method for cultivating seaweed and method for producing alginic acid-containing composition
03/14/2013WO2013035779A1 Method of analysis of intercell interactions
03/14/2013WO2013035757A1 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
03/14/2013WO2013035712A1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis
03/14/2013WO2013035579A1 Liver-accumulative nanoparticle having drug encapsulated therein
03/14/2013WO2013035479A1 Composition for improving in vivo metabolism parameter
03/14/2013WO2013035423A1 Pharmaceutical composition containing candesartan cilexetil
03/14/2013WO2013035331A1 Oral composition
03/14/2013WO2013035113A1 Coated suppositories
03/14/2013WO2013035109A1 Improved process for the preparation of asenapine maleate
03/14/2013WO2013035072A1 Bioactive nanofibres
03/14/2013WO2013035053A2 Novel conjugation-facilitated transport of drugs across blood brain barrier
03/14/2013WO2013035047A1 Benzothiazolone compound
03/14/2013WO2013034931A1 Oral suspension
03/14/2013WO2013034927A1 Compositions of lopinavir and ritonavir
03/14/2013WO2013034926A1 Compositions of lopinavir
03/14/2013WO2013034925A1 Compositions of efavirenz
03/14/2013WO2013034910A1 Inhalable compositions
03/14/2013WO2013034909A1 Treating cough and tussive attacks
03/14/2013WO2013034863A1 Scheme for administering n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)­benzofuran-2-ylcarbonylamino]ethoxy}benzamide
03/14/2013WO2013034806A1 Pharmaceutical combination comprising a cip2a silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired p53 function
03/14/2013WO2013034761A1 Pyridine compounds and uses thereof
03/14/2013WO2013034758A1 Substituted triazolopyrazines and uses thereof
03/14/2013WO2013034756A1 Biphenyl compounds for use in treating malaria and other parasitic disorders
03/14/2013WO2013034755A1 Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders
03/14/2013WO2013034746A1 Anti-inflammatory compositions comprising malvidin - 3 - o - beta-glucoside and a propolis extract
03/14/2013WO2013034707A1 Use of adamantane derivatives for the treatment of actinic keratosis
03/14/2013WO2013034685A1 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
03/14/2013WO2013034684A1 Strategies for prevention and/or treatment of diseases based on cd40 silencing
03/14/2013WO2013034653A1 The mirna-212/132 family as a therapeutic target
03/14/2013WO2013034622A1 Polymorphic form of pridopidine hydrochloride
03/14/2013WO2013034570A1 Amino-substituted imidazopyridazines
03/14/2013WO2013034550A1 Pramipexole extended release tablets
03/14/2013WO2013034506A1 Pde10 modulators
03/14/2013WO2013034457A1 Lipophilic dopamine derivatives and their use
03/14/2013WO2013034299A1 Therapeutic uses of ectoin
03/14/2013WO2013034292A1 Pharmaceutical compositions containing carboxylated starch
03/14/2013WO2013034238A1 Benzonitrile derivatives as kinase inhibitors
03/14/2013WO2013034174A1 Solid preparations of pioglitazone and glimepiride
03/14/2013WO2013034173A1 Pramipexole extended release tablets
03/14/2013WO2013034119A1 4-methylcatechol derivatives und use thereof
03/14/2013WO2013034098A1 Combination use of vitamin d and hmg coa reductase inhibitor for treating osteoporosis
1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 7860